Quote | Cartesian Growth Corporation II (NASDAQ:RENE)
Last: | $11.23 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $11.23 |
High: | $0 |
Low: | $0 |
Volume: | 66 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Cartesian Growth Corporation II (NASDAQ:RENE)
2024-04-27 01:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-17 05:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Cartesian Growth Corporation II (NASDAQ:RENE)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Cartesian Growth Corporation II Company Name:
RENE Stock Symbol:
NASDAQ Market:
2024-04-27 01:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-17 05:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
(NewsDirect) ReNeuron Group PLC executive chairman Iain Ross tells Proactive that the company is focused on generating in vivo data and validating its exosome delivery technology platform CustomEX as 2023 gets underway. ReNeuron will conduct head-to-head studies with its competitors to pr...